SALAROGLIO, Iris Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.337
EU - Europa 1.741
AS - Asia 1.399
AF - Africa 44
SA - Sud America 19
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.559
Nazione #
US - Stati Uniti d'America 2.254
CN - Cina 853
IT - Italia 635
SE - Svezia 182
IE - Irlanda 165
AT - Austria 156
FR - Francia 127
SG - Singapore 126
HK - Hong Kong 109
DE - Germania 100
GB - Regno Unito 73
JP - Giappone 70
UA - Ucraina 54
TW - Taiwan 49
CA - Canada 48
PL - Polonia 48
FI - Finlandia 38
IN - India 37
VN - Vietnam 36
MX - Messico 35
KR - Corea 28
BE - Belgio 27
ES - Italia 20
EG - Egitto 19
IR - Iran 19
NL - Olanda 19
TR - Turchia 17
DK - Danimarca 16
AU - Australia 14
PT - Portogallo 14
GR - Grecia 13
RU - Federazione Russa 12
CH - Svizzera 11
ID - Indonesia 10
SN - Senegal 9
BR - Brasile 8
NO - Norvegia 8
HU - Ungheria 7
MA - Marocco 6
RO - Romania 6
TH - Thailandia 6
AM - Armenia 4
AR - Argentina 4
BD - Bangladesh 4
CL - Cile 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
MY - Malesia 4
NG - Nigeria 4
UZ - Uzbekistan 4
IL - Israele 3
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
BQ - ???statistics.table.value.countryCode.BQ??? 2
EC - Ecuador 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
PK - Pakistan 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
EU - Europa 1
JO - Giordania 1
LV - Lettonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TN - Tunisia 1
Totale 5.559
Città #
Chandler 252
Torino 206
Beijing 181
Fairfield 166
Ashburn 164
Dublin 161
Vienna 154
Houston 113
Woodbridge 99
Ann Arbor 94
Turin 78
Wilmington 77
Seattle 75
Dearborn 64
Cambridge 61
Nyköping 58
Singapore 54
Guangzhou 51
New York 49
Pisa 48
Redwood City 44
Shanghai 40
Princeton 38
Central 37
Hangzhou 37
Nanjing 34
Taipei 34
Medford 31
Fremont 29
Villeurbanne 28
Warsaw 26
Changsha 24
Jacksonville 23
Wuhan 22
Milan 21
Boardman 19
Boston 19
Brussels 18
Dong Ket 18
Helsinki 18
London 18
Los Angeles 18
Paris 16
San Jose 16
San Diego 15
Shenzhen 15
Tokyo 15
Toronto 15
Frankfurt am Main 14
Hong Kong 14
Tianjin 14
Chengdu 13
Xian 13
Rome 12
Shenyang 12
Buffalo 11
Cairo 11
Jinan 11
Brescia 10
Central District 10
Seoul 10
Chicago 9
Chongqing 9
Hebei 9
Ottawa 9
Changchun 8
Dallas 8
Fuzhou 8
Hefei 8
San Francisco 8
Suzhou 8
Istanbul 7
Kunming 7
Mexico 7
San Giuliano Milanese 7
Silver Spring 7
Barcelona 6
Bethesda 6
Camporosso 6
Detroit 6
Florence 6
Hamburg 6
Heidelberg 6
Jakarta 6
Kharkiv 6
Lexington 6
Mumbai 6
Osaka 6
Piemonte 6
Tappahannock 6
Xiamen 6
Angers 5
Athens 5
Birmingham 5
Bordeaux 5
Budapest 5
Changzhou 5
Dalian 5
Duncan 5
Düsseldorf 5
Totale 3.302
Nome #
Impact of cancer metabolism on therapy resistance – Clinical implications 566
Hypoxia as a driver of resistance to immunotherapy 537
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 459
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 293
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 250
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy 248
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 240
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 238
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 227
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 165
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 156
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 142
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. 138
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 128
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 124
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 122
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 120
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 108
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 105
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors 104
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 103
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells 98
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 98
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 80
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 79
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 71
GIFC-2018 - BOOK OF ABSTRACTS 70
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 69
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 66
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 66
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation 63
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 62
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 61
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 60
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 57
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression 25
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 24
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 23
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells 22
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors 15
Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models 7
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma 6
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition 3
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs 3
Totale 5.701
Categoria #
all - tutte 14.965
article - articoli 0
book - libri 0
conference - conferenze 1.131
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020661 22 17 28 51 41 83 81 65 71 77 64 61
2020/2021789 35 75 47 65 83 72 51 57 60 85 84 75
2021/2022742 54 31 34 90 30 33 41 43 33 62 167 124
2022/20231.175 92 74 51 92 117 205 98 100 139 54 60 93
2023/20241.277 115 129 92 104 82 160 125 88 38 126 107 111
2024/202545 45 0 0 0 0 0 0 0 0 0 0 0
Totale 5.701